Using Neonatal Magnetic Resonance Imaging to Predict Gross Motor Disability at Four Years in Term-Born Children With Neonatal Encephalopathy.


Journal

Pediatric neurology
ISSN: 1873-5150
Titre abrégé: Pediatr Neurol
Pays: United States
ID NLM: 8508183

Informations de publication

Date de publication:
07 2023
Historique:
received: 27 09 2022
revised: 07 11 2022
accepted: 17 03 2023
medline: 16 6 2023
pubmed: 7 5 2023
entrez: 6 5 2023
Statut: ppublish

Résumé

Children with neonatal encephalopathy (NE) are at risk for basal ganglia/thalamus (BG/T) and watershed patterns of brain injury. Children with BG/T injury are at high risk for motor impairment in infancy, but the predictive validity of a published rating scale for outcome at age four years is not known. We examined a cohort of children with NE and magnetic resonance imaging (MRI) to examine the relationship between BG/T injury and severity of cerebral palsy (CP) in childhood. Term-born neonates at risk for brain injury due to NE were enrolled from 1993 to 2014 and received MRI within two weeks of birth. Brain injury was scored by a pediatric neuroradiologist. The Gross Motor Function Classification System (GMFCS) level was determined at four years. The relationship between BG/T injury and dichotomized GMFCS (no CP or GMFCS I to II = none/mild versus III to V = moderate/severe CP) was evaluated with logistic regression, and predictive performance was assessed by cross-validated area under the receiver operating characteristic curve (AUROC). Among 174 children, higher BG/T scores were associated with more severe GMFCS level. Clinical predictors had a low AUROC (0.599), compared with that of MRI (0.895). Risk of moderate to severe CP was low (<20%) in all patterns of brain injury except BG/T = 4, which carried a 67% probability (95% confidence interval 36% to 98%) of moderate to severe CP. The BG/T injury score can be used to predict the risk and severity of CP at age four years and thereby inform early developmental interventions.

Sections du résumé

BACKGROUND
Children with neonatal encephalopathy (NE) are at risk for basal ganglia/thalamus (BG/T) and watershed patterns of brain injury. Children with BG/T injury are at high risk for motor impairment in infancy, but the predictive validity of a published rating scale for outcome at age four years is not known. We examined a cohort of children with NE and magnetic resonance imaging (MRI) to examine the relationship between BG/T injury and severity of cerebral palsy (CP) in childhood.
METHODS
Term-born neonates at risk for brain injury due to NE were enrolled from 1993 to 2014 and received MRI within two weeks of birth. Brain injury was scored by a pediatric neuroradiologist. The Gross Motor Function Classification System (GMFCS) level was determined at four years. The relationship between BG/T injury and dichotomized GMFCS (no CP or GMFCS I to II = none/mild versus III to V = moderate/severe CP) was evaluated with logistic regression, and predictive performance was assessed by cross-validated area under the receiver operating characteristic curve (AUROC).
RESULTS
Among 174 children, higher BG/T scores were associated with more severe GMFCS level. Clinical predictors had a low AUROC (0.599), compared with that of MRI (0.895). Risk of moderate to severe CP was low (<20%) in all patterns of brain injury except BG/T = 4, which carried a 67% probability (95% confidence interval 36% to 98%) of moderate to severe CP.
CONCLUSIONS
The BG/T injury score can be used to predict the risk and severity of CP at age four years and thereby inform early developmental interventions.

Identifiants

pubmed: 37148603
pii: S0887-8994(23)00089-9
doi: 10.1016/j.pediatrneurol.2023.03.011
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-55

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB009756
Pays : United States
Organisme : NINDS NIH HHS
ID : P01 NS082330
Pays : United States

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Hannah Lambing (H)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.

Dawn Gano (D)

Department of Neurology and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California; Department of Pediatrics and Benioff Children's Hospital, University of California San Francisco, San Francisco, California.

Yi Li (Y)

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.

Ashley M Bach (AM)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Olivia Girvan (O)

Johns Hopkins University, Baltimore, Maryland.

Elizabeth E Rogers (EE)

Department of Pediatrics and Benioff Children's Hospital, University of California San Francisco, San Francisco, California.

Donna M Ferriero (DM)

Department of Neurology and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California; Department of Pediatrics and Benioff Children's Hospital, University of California San Francisco, San Francisco, California.

A James Barkovich (AJ)

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.

Duan Xu (D)

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.

Charles E McCulloch (CE)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.

Hannah C Glass (HC)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California; Department of Neurology and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California; Department of Pediatrics and Benioff Children's Hospital, University of California San Francisco, San Francisco, California. Electronic address: Hannah.Glass@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH